Literature DB >> 6893628

Dantrolene and lymphocytic lymphoma.

H H Wan, J S Tucker.   

Abstract

A patient is reported who was on prolonged treatment with dantrolene for spastic paraplegia; he developed a malignant lymphoma which led to his death.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6893628      PMCID： PMC2425904          DOI： 10.1136/pgmj.56.654.261

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  4 in total

1.  Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas.

Authors:  S L SALTZSTEIN; L V ACKERMAN
Journal:  Cancer       Date:  1959 Jan-Feb       Impact factor: 6.860

2.  The development of Hodgkin's disease and lymphoma during anticonvulsant therapy.

Authors:  G A Hyman; S C Sommers
Journal:  Blood       Date:  1966-09       Impact factor: 22.113

3.  Hydantoin-induced pseudo-pseudolymphoma.

Authors:  R A Gams; J A Neal; F G Conrad
Journal:  Ann Intern Med       Date:  1968-09       Impact factor: 25.391

4.  Malignant lymphoma associated with hydantoin drugs.

Authors:  J J Anthony
Journal:  Arch Neurol       Date:  1970-05
  4 in total
  2 in total

Review 1.  Dantrolene.

Authors:  B A Britt
Journal:  Can Anaesth Soc J       Date:  1984-01

Review 2.  Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity.

Authors:  A Ward; M O Chaffman; E M Sorkin
Journal:  Drugs       Date:  1986-08       Impact factor: 9.546
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.